Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 401-425 of 861 matching filings.

Per page
25
Current page
17
SC 13G File 005-81034

SC 13G

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K WOLFF APPOINTMENT

Filing date
07 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 1

Filing date
07 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
06 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K 2018 BONUS PROGRAM

Filing date
05 Feb 2018
Reporting date
30 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Jan 2018
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
15 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Dec 2017
Reporting date
30 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
04 Dec 2017
Reporting date
30 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
04 Dec 2017
Reporting date
02 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
30 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-218607

EFFECT filing

Filing date
21 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-218607

424B5

Filing date
21 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-218607

424B5

Filing date
21 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SC 13G

Filing date
13 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-218607

S-3/A

Filing date
07 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81034

AMENDMENT NO. 5 TO SCHEDULE 13D

Filing date
07 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SC 13G filing

Filing date
06 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
02 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
31 Oct 2017
Reporting date
27 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .